Arkolith/Insider Trading/CINC/Form 4

Gap Coinvestments III, LLC

10% OwnerCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Jan 13, 2022
Net Buying
Open-Market Buys
$27.2M
Open-Market Sells
$0
Net Open-Market Flow
$27.2M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 11, 2022Buy(P)1.7M$16.00$27.2M4.1M
Jan 11, 2022Conversion(C)2.4M——2.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 11, 2022Conversion(C)8.3M——0

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950142-22-000343) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML